世界のリソソーム蓄積症治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Lysosomal Storage Disease Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4451
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、95ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、リソソーム蓄積症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（酵素補充療法、幹細胞移植、基質減少療法、その他）、用途別市場規模（病院、クリニック、幹細胞移植センター、研究機関、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・リソソーム蓄積症治療の市場動向
・企業の競争状況、市場シェア
・リソソーム蓄積症治療の種類別市場規模と予測2016-2027（酵素補充療法、幹細胞移植、基質減少療法、その他）
・リソソーム蓄積症治療の用途別市場規模と予測2016-2027（病院、クリニック、幹細胞移植センター、研究機関、その他）
・リソソーム蓄積症治療の北米市場規模2016-2027（アメリカ、カナダ）
・リソソーム蓄積症治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・リソソーム蓄積症治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・リソソーム蓄積症治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・リソソーム蓄積症治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Takeda、Pfizer、Sanofi、BioMarin、Merck、Actelion Pharmaceuticals、Eli Lilly）
・結論

Lysosomal storage disease (LTD) is caused by defect in lysosomal functions and degradation pathway. It is caused by progressive accumulation of metabolites. LTD is a rare inherited metabolic disorder.

Market Analysis and Insights: Global Lysosomal Storage Disease Treatment Market
The global Lysosomal Storage Disease Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Lysosomal Storage Disease Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Lysosomal Storage Disease Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Lysosomal Storage Disease Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Lysosomal Storage Disease Treatment market.

Global Lysosomal Storage Disease Treatment Scope and Market Size
Lysosomal Storage Disease Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Lysosomal Storage Disease Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Enzyme Replacement Therapy
Stem Cell Transplantation
Substrate Reduction Therapy
Others

Segment by Application
Hospitals
Clinics
Stem Transplant Centers
Research Organizations
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Takeda
Pfizer
Sanofi
BioMarin
Merck
Actelion Pharmaceuticals
Eli Lilly

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Lysosomal Storage Disease Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Enzyme Replacement Therapy
1.2.3 Stem Cell Transplantation
1.2.4 Substrate Reduction Therapy
1.2.5 Others
1.3 Market by Application
1.3.1 Global Lysosomal Storage Disease Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Stem Transplant Centers
1.3.5 Research Organizations
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Lysosomal Storage Disease Treatment Market Perspective (2016-2027)
2.2 Lysosomal Storage Disease Treatment Growth Trends by Regions
2.2.1 Lysosomal Storage Disease Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Lysosomal Storage Disease Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Lysosomal Storage Disease Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Lysosomal Storage Disease Treatment Industry Dynamic
2.3.1 Lysosomal Storage Disease Treatment Market Trends
2.3.2 Lysosomal Storage Disease Treatment Market Drivers
2.3.3 Lysosomal Storage Disease Treatment Market Challenges
2.3.4 Lysosomal Storage Disease Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Lysosomal Storage Disease Treatment Players by Revenue
3.1.1 Global Top Lysosomal Storage Disease Treatment Players by Revenue (2016-2021)
3.1.2 Global Lysosomal Storage Disease Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Lysosomal Storage Disease Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Lysosomal Storage Disease Treatment Revenue
3.4 Global Lysosomal Storage Disease Treatment Market Concentration Ratio
3.4.1 Global Lysosomal Storage Disease Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Lysosomal Storage Disease Treatment Revenue in 2020
3.5 Lysosomal Storage Disease Treatment Key Players Head office and Area Served
3.6 Key Players Lysosomal Storage Disease Treatment Product Solution and Service
3.7 Date of Enter into Lysosomal Storage Disease Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Lysosomal Storage Disease Treatment Breakdown Data by Type
4.1 Global Lysosomal Storage Disease Treatment Historic Market Size by Type (2016-2021)
4.2 Global Lysosomal Storage Disease Treatment Forecasted Market Size by Type (2022-2027)

5 Lysosomal Storage Disease Treatment Breakdown Data by Application
5.1 Global Lysosomal Storage Disease Treatment Historic Market Size by Application (2016-2021)
5.2 Global Lysosomal Storage Disease Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Lysosomal Storage Disease Treatment Market Size (2016-2027)
6.2 North America Lysosomal Storage Disease Treatment Market Size by Type
6.2.1 North America Lysosomal Storage Disease Treatment Market Size by Type (2016-2021)
6.2.2 North America Lysosomal Storage Disease Treatment Market Size by Type (2022-2027)
6.2.3 North America Lysosomal Storage Disease Treatment Market Size by Type (2016-2027)
6.3 North America Lysosomal Storage Disease Treatment Market Size by Application
6.3.1 North America Lysosomal Storage Disease Treatment Market Size by Application (2016-2021)
6.3.2 North America Lysosomal Storage Disease Treatment Market Size by Application (2022-2027)
6.3.3 North America Lysosomal Storage Disease Treatment Market Size by Application (2016-2027)
6.4 North America Lysosomal Storage Disease Treatment Market Size by Country
6.4.1 North America Lysosomal Storage Disease Treatment Market Size by Country (2016-2021)
6.4.2 North America Lysosomal Storage Disease Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Lysosomal Storage Disease Treatment Market Size (2016-2027)
7.2 Europe Lysosomal Storage Disease Treatment Market Size by Type
7.2.1 Europe Lysosomal Storage Disease Treatment Market Size by Type (2016-2021)
7.2.2 Europe Lysosomal Storage Disease Treatment Market Size by Type (2022-2027)
7.2.3 Europe Lysosomal Storage Disease Treatment Market Size by Type (2016-2027)
7.3 Europe Lysosomal Storage Disease Treatment Market Size by Application
7.3.1 Europe Lysosomal Storage Disease Treatment Market Size by Application (2016-2021)
7.3.2 Europe Lysosomal Storage Disease Treatment Market Size by Application (2022-2027)
7.3.3 Europe Lysosomal Storage Disease Treatment Market Size by Application (2016-2027)
7.4 Europe Lysosomal Storage Disease Treatment Market Size by Country
7.4.1 Europe Lysosomal Storage Disease Treatment Market Size by Country (2016-2021)
7.4.2 Europe Lysosomal Storage Disease Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Lysosomal Storage Disease Treatment Market Size (2016-2027)
8.2 Asia-Pacific Lysosomal Storage Disease Treatment Market Size by Type
8.2.1 Asia-Pacific Lysosomal Storage Disease Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Lysosomal Storage Disease Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Lysosomal Storage Disease Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Lysosomal Storage Disease Treatment Market Size by Application
8.3.1 Asia-Pacific Lysosomal Storage Disease Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Lysosomal Storage Disease Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Lysosomal Storage Disease Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Lysosomal Storage Disease Treatment Market Size by Region
8.4.1 Asia-Pacific Lysosomal Storage Disease Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Lysosomal Storage Disease Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Lysosomal Storage Disease Treatment Market Size (2016-2027)
9.2 Latin America Lysosomal Storage Disease Treatment Market Size by Type
9.2.1 Latin America Lysosomal Storage Disease Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Lysosomal Storage Disease Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Lysosomal Storage Disease Treatment Market Size by Type (2016-2027)
9.3 Latin America Lysosomal Storage Disease Treatment Market Size by Application
9.3.1 Latin America Lysosomal Storage Disease Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Lysosomal Storage Disease Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Lysosomal Storage Disease Treatment Market Size by Application (2016-2027)
9.4 Latin America Lysosomal Storage Disease Treatment Market Size by Country
9.4.1 Latin America Lysosomal Storage Disease Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Lysosomal Storage Disease Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Lysosomal Storage Disease Treatment Market Size (2016-2027)
10.2 Middle East & Africa Lysosomal Storage Disease Treatment Market Size by Type
10.2.1 Middle East & Africa Lysosomal Storage Disease Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Lysosomal Storage Disease Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Lysosomal Storage Disease Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Lysosomal Storage Disease Treatment Market Size by Application
10.3.1 Middle East & Africa Lysosomal Storage Disease Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Lysosomal Storage Disease Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Lysosomal Storage Disease Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Lysosomal Storage Disease Treatment Market Size by Country
10.4.1 Middle East & Africa Lysosomal Storage Disease Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Lysosomal Storage Disease Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Takeda
11.1.1 Takeda Company Details
11.1.2 Takeda Business Overview
11.1.3 Takeda Lysosomal Storage Disease Treatment Introduction
11.1.4 Takeda Revenue in Lysosomal Storage Disease Treatment Business (2016-2021)
11.1.5 Takeda Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Lysosomal Storage Disease Treatment Introduction
11.2.4 Pfizer Revenue in Lysosomal Storage Disease Treatment Business (2016-2021)
11.2.5 Pfizer Recent Development
11.3 Sanofi
11.3.1 Sanofi Company Details
11.3.2 Sanofi Business Overview
11.3.3 Sanofi Lysosomal Storage Disease Treatment Introduction
11.3.4 Sanofi Revenue in Lysosomal Storage Disease Treatment Business (2016-2021)
11.3.5 Sanofi Recent Development
11.4 BioMarin
11.4.1 BioMarin Company Details
11.4.2 BioMarin Business Overview
11.4.3 BioMarin Lysosomal Storage Disease Treatment Introduction
11.4.4 BioMarin Revenue in Lysosomal Storage Disease Treatment Business (2016-2021)
11.4.5 BioMarin Recent Development
11.5 Merck
11.5.1 Merck Company Details
11.5.2 Merck Business Overview
11.5.3 Merck Lysosomal Storage Disease Treatment Introduction
11.5.4 Merck Revenue in Lysosomal Storage Disease Treatment Business (2016-2021)
11.5.5 Merck Recent Development
11.6 Actelion Pharmaceuticals
11.6.1 Actelion Pharmaceuticals Company Details
11.6.2 Actelion Pharmaceuticals Business Overview
11.6.3 Actelion Pharmaceuticals Lysosomal Storage Disease Treatment Introduction
11.6.4 Actelion Pharmaceuticals Revenue in Lysosomal Storage Disease Treatment Business (2016-2021)
11.6.5 Actelion Pharmaceuticals Recent Development
11.7 Eli Lilly
11.7.1 Eli Lilly Company Details
11.7.2 Eli Lilly Business Overview
11.7.3 Eli Lilly Lysosomal Storage Disease Treatment Introduction
11.7.4 Eli Lilly Revenue in Lysosomal Storage Disease Treatment Business (2016-2021)
11.7.5 Eli Lilly Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Lysosomal Storage Disease Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Enzyme Replacement Therapy
Table 3. Key Players of Stem Cell Transplantation
Table 4. Key Players of Substrate Reduction Therapy
Table 5. Key Players of Others
Table 6. Global Lysosomal Storage Disease Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Lysosomal Storage Disease Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Lysosomal Storage Disease Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Lysosomal Storage Disease Treatment Market Share by Regions (2016-2021)
Table 10. Global Lysosomal Storage Disease Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Lysosomal Storage Disease Treatment Market Share by Regions (2022-2027)
Table 12. Lysosomal Storage Disease Treatment Market Trends
Table 13. Lysosomal Storage Disease Treatment Market Drivers
Table 14. Lysosomal Storage Disease Treatment Market Challenges
Table 15. Lysosomal Storage Disease Treatment Market Restraints
Table 16. Global Lysosomal Storage Disease Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Lysosomal Storage Disease Treatment Market Share by Players (2016-2021)
Table 18. Global Top Lysosomal Storage Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lysosomal Storage Disease Treatment as of 2020)
Table 19. Ranking of Global Top Lysosomal Storage Disease Treatment Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Lysosomal Storage Disease Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Lysosomal Storage Disease Treatment Product Solution and Service
Table 23. Date of Enter into Lysosomal Storage Disease Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Lysosomal Storage Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Lysosomal Storage Disease Treatment Revenue Market Share by Type (2016-2021)
Table 27. Global Lysosomal Storage Disease Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Lysosomal Storage Disease Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Lysosomal Storage Disease Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Lysosomal Storage Disease Treatment Revenue Market Share by Application (2016-2021)
Table 31. Global Lysosomal Storage Disease Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Lysosomal Storage Disease Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Lysosomal Storage Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Lysosomal Storage Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Lysosomal Storage Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Lysosomal Storage Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Lysosomal Storage Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Lysosomal Storage Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Lysosomal Storage Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Lysosomal Storage Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Lysosomal Storage Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Lysosomal Storage Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Lysosomal Storage Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Lysosomal Storage Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Lysosomal Storage Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Lysosomal Storage Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Lysosomal Storage Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Lysosomal Storage Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Lysosomal Storage Disease Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Lysosomal Storage Disease Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Lysosomal Storage Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Lysosomal Storage Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Lysosomal Storage Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Lysosomal Storage Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Lysosomal Storage Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Lysosomal Storage Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Lysosomal Storage Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Lysosomal Storage Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Lysosomal Storage Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Lysosomal Storage Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Lysosomal Storage Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Lysosomal Storage Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 63. Takeda Company Details
Table 64. Takeda Business Overview
Table 65. Takeda Lysosomal Storage Disease Treatment Product
Table 66. Takeda Revenue in Lysosomal Storage Disease Treatment Business (2016-2021) & (US$ Million)
Table 67. Takeda Recent Development
Table 68. Pfizer Company Details
Table 69. Pfizer Business Overview
Table 70. Pfizer Lysosomal Storage Disease Treatment Product
Table 71. Pfizer Revenue in Lysosomal Storage Disease Treatment Business (2016-2021) & (US$ Million)
Table 72. Pfizer Recent Development
Table 73. Sanofi Company Details
Table 74. Sanofi Business Overview
Table 75. Sanofi Lysosomal Storage Disease Treatment Product
Table 76. Sanofi Revenue in Lysosomal Storage Disease Treatment Business (2016-2021) & (US$ Million)
Table 77. Sanofi Recent Development
Table 78. BioMarin Company Details
Table 79. BioMarin Business Overview
Table 80. BioMarin Lysosomal Storage Disease Treatment Product
Table 81. BioMarin Revenue in Lysosomal Storage Disease Treatment Business (2016-2021) & (US$ Million)
Table 82. BioMarin Recent Development
Table 83. Merck Company Details
Table 84. Merck Business Overview
Table 85. Merck Lysosomal Storage Disease Treatment Product
Table 86. Merck Revenue in Lysosomal Storage Disease Treatment Business (2016-2021) & (US$ Million)
Table 87. Merck Recent Development
Table 88. Actelion Pharmaceuticals Company Details
Table 89. Actelion Pharmaceuticals Business Overview
Table 90. Actelion Pharmaceuticals Lysosomal Storage Disease Treatment Product
Table 91. Actelion Pharmaceuticals Revenue in Lysosomal Storage Disease Treatment Business (2016-2021) & (US$ Million)
Table 92. Actelion Pharmaceuticals Recent Development
Table 93. Eli Lilly Company Details
Table 94. Eli Lilly Business Overview
Table 95. Eli Lilly Lysosomal Storage Disease Treatment Product
Table 96. Eli Lilly Revenue in Lysosomal Storage Disease Treatment Business (2016-2021) & (US$ Million)
Table 97. Eli Lilly Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Lysosomal Storage Disease Treatment Market Share by Type: 2020 VS 2027
Figure 2. Enzyme Replacement Therapy Features
Figure 3. Stem Cell Transplantation Features
Figure 4. Substrate Reduction Therapy Features
Figure 5. Others Features
Figure 6. Global Lysosomal Storage Disease Treatment Market Share by Application: 2020 VS 2027
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Stem Transplant Centers Case Studies
Figure 10. Research Organizations Case Studies
Figure 11. Others Case Studies
Figure 12. Lysosomal Storage Disease Treatment Report Years Considered
Figure 13. Global Lysosomal Storage Disease Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Lysosomal Storage Disease Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Lysosomal Storage Disease Treatment Market Share by Regions: 2020 VS 2027
Figure 16. Global Lysosomal Storage Disease Treatment Market Share by Regions (2022-2027)
Figure 17. Global Lysosomal Storage Disease Treatment Market Share by Players in 2020
Figure 18. Global Top Lysosomal Storage Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lysosomal Storage Disease Treatment as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Lysosomal Storage Disease Treatment Revenue in 2020
Figure 20. Global Lysosomal Storage Disease Treatment Revenue Market Share by Type (2016-2021)
Figure 21. Global Lysosomal Storage Disease Treatment Revenue Market Share by Type (2022-2027)
Figure 22. North America Lysosomal Storage Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Lysosomal Storage Disease Treatment Market Share by Type (2016-2027)
Figure 24. North America Lysosomal Storage Disease Treatment Market Share by Application (2016-2027)
Figure 25. North America Lysosomal Storage Disease Treatment Market Share by Country (2016-2027)
Figure 26. United States Lysosomal Storage Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Lysosomal Storage Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Lysosomal Storage Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Lysosomal Storage Disease Treatment Market Share by Type (2016-2027)
Figure 30. Europe Lysosomal Storage Disease Treatment Market Share by Application (2016-2027)
Figure 31. Europe Lysosomal Storage Disease Treatment Market Share by Country (2016-2027)
Figure 32. Germany Lysosomal Storage Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Lysosomal Storage Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Lysosomal Storage Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Lysosomal Storage Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Lysosomal Storage Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Lysosomal Storage Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Lysosomal Storage Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Lysosomal Storage Disease Treatment Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Lysosomal Storage Disease Treatment Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Lysosomal Storage Disease Treatment Market Share by Region (2016-2027)
Figure 42. China Lysosomal Storage Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Lysosomal Storage Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Lysosomal Storage Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Lysosomal Storage Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Lysosomal Storage Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Lysosomal Storage Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Lysosomal Storage Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Lysosomal Storage Disease Treatment Market Share by Type (2016-2027)
Figure 50. Latin America Lysosomal Storage Disease Treatment Market Share by Application (2016-2027)
Figure 51. Latin America Lysosomal Storage Disease Treatment Market Share by Country (2016-2027)
Figure 52. Mexico Lysosomal Storage Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Lysosomal Storage Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Lysosomal Storage Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Lysosomal Storage Disease Treatment Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Lysosomal Storage Disease Treatment Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Lysosomal Storage Disease Treatment Market Share by Country (2016-2027)
Figure 58. Turkey Lysosomal Storage Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Lysosomal Storage Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Lysosomal Storage Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Takeda Revenue Growth Rate in Lysosomal Storage Disease Treatment Business (2016-2021)
Figure 62. Pfizer Revenue Growth Rate in Lysosomal Storage Disease Treatment Business (2016-2021)
Figure 63. Sanofi Revenue Growth Rate in Lysosomal Storage Disease Treatment Business (2016-2021)
Figure 64. BioMarin Revenue Growth Rate in Lysosomal Storage Disease Treatment Business (2016-2021)
Figure 65. Merck Revenue Growth Rate in Lysosomal Storage Disease Treatment Business (2016-2021)
Figure 66. Actelion Pharmaceuticals Revenue Growth Rate in Lysosomal Storage Disease Treatment Business (2016-2021)
Figure 67. Eli Lilly Revenue Growth Rate in Lysosomal Storage Disease Treatment Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

以下、関連資料のご紹介

世界のライソゾーム病治療市場規模・現状・予測（2021年-2027年）

Global Lysosomal Disease Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5232 2021年6月 105Pages
QYResearch社発行の本調査レポートでは、ライソゾーム病治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（造血幹細胞移植、酵素補充療法、基質減少、シャペロン療法）、用途別市場規模（病院、クリニック、幹細胞移植センター、研究機関、その他）、主...

世界のグリコーゲン代謝＆糖原病治療市場規模・現状・予測（2021年-2027年）

Global Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5757 2021年6月 109Pages
QYResearch社発行の本調査レポートでは、グリコーゲン代謝＆糖原病治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（OTC、Rx薬剤）、用途別市場規模（病院、小売薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、イ...

世界のフォン・ヴィレブランド病治療市場規模・現状・予測（2021年-2027年）

Global Von Willebrand Disease Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5033 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、フォン・ヴィレブランド病治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（Veyvondi、Humate-P、Alphanate、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模...

世界のペイロニー病治療市場規模・現状・予測（2021年-2027年）

Global Peyronie’s Disease Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4696 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、ペイロニー病治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（治療薬、手術）、用途別市場規模（病院、ドラッグストア）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南...

世界のバッテン病治療市場規模・現状・予測（2021年-2027年）

Global Batten Disease Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3891 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、バッテン病治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（作業療法、理学療法）、用途別市場規模（乳児NCL、後期乳児NCL、少年NCL、成人NCL）、主要地域別市場規模（北米、アメリカ、欧州、アジ...

世界のアジソン病用治療市場規模・現状・予測（2021年-2027年）

Global Addison's Disease Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3763 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、アジソン病用治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口コルチコステロイド、コルチコステロイド注射）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジ...

世界の多発性嚢胞腎治療薬市場規模・現状・予測（2021年-2027年）

Global Polycystic Kidney Disease Treatment Drugs Market Size, Status and Forecast 2021-2027
QFJ1-4730 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、多発性嚢胞腎治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ANG-3070、CIM-2、CR-8、その他）、用途別市場規模（常染色体優性多発性嚢胞腎（ADPKD）、常染色体劣性多発性嚢胞腎（A...

世界のICAD (頭蓋内アテローム性動脈硬化症) 病理学治療市場規模・現状・予測（2021年-2027年）

Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5203 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、ICAD (頭蓋内アテローム性動脈硬化症) 病理学治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ステント、PTAバルーン）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメ...

世界のパジェット病治療市場規模・現状・予測（2021年-2027年）

Global Paget's Disease Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4647 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、パジェット病治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ビスフォスフォネート、カルシトニン類似体（サーモンカルシトニン）、鎮痛剤、カルシウム・ビタミンDサプリメント）、用途別市場規模（病院、ク...

世界の認知症＆アルツハイマー病治療市場規模・現状・予測（2021年-2027年）

Global Dementia and Alzheimer’s Disease Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5693 2021年6月 108Pages
QYResearch社発行の本調査レポートでは、認知症＆アルツハイマー病治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（コリンエステラーゼ阻害剤、メマンチン、併用薬）、用途別市場規模（病院、診療所）、主要地域別市場規模（北米、アメリカ、欧州、ア...

世界のライソゾーム病治療市場規模・現状・予測（2021年-2027年） Lysosomal disease treatment is a way to alleviate Lysosomal storage disease. Lysosomal disease is caused by defects in lysosomal function and degradation pathways. It is caused by the gradual accumulation of metabolites. Market Analysis and Insights: Global Lysosomal Disease Treatment Market The glo…
世界の胎盤幹細胞療法市場規模・現状・予測（2021年-2027年） Placental stem cells are cells derived from the placental blood and other body fluids of a new-born baby. Stem cells are human cells classified into a different variety of cell types, including brain and muscle cells. Stem cells are sometimes used in the development of regenerative therapies. Regene…
世界の幹細胞バンク保存市場規模・現状・予測（2021年-2027年） Stem Cell Banking refers to the human stem cell transplantation for the purpose, with acquisition, processing, preservation and provides the ability to differentiate stem cell storage bank, has been called the "life bank". Market Analysis and Insights: Global Stem Cell Banking Storage Market The glo…
世界の同種異系幹細胞治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Allogeneic Stem Cell Therapy Market The global Allogeneic Stem Cell Therapy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integri…
世界のグリコーゲン代謝＆糖原病治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Glycogen Metabolism and Glycogen Storage Disease Treatment Market The global Glycogen Metabolism and Glycogen Storage Disease Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With …